meso-Tetraarylazuliporphyrins under LindseyϪRothemund Reaction Conditions
8.47Ϫ8.52 (m, H) ppm. HRMS (FAB): calculated for 108.6, 117.6, 117.8, 122.0, 122.1, 123.9, 125.8, 125.9, 126.3, 127.1,
FULL PAPER
4
C50H13F20N3 ϩ H: m/z ϭ 1036.0868; found 1036.0865.
127.4, 127.5, 127.6, 128.5, 128.7, 128.8, 132.8, 133.1, 134.2, 134.3,
134.7, 134.8, 135.1, 135.8, 135.9, 136.4, 138.1, 138.2, 138.3, 139.2,
139.3, 139.9, 140.0, 140.3, 140.4, 142.2, 155.9, 192.2 ppm. HRMS
(FAB): calculated for C50H29N3Cl4O ϩ H: m/z ϭ 828.1143; found
828.1139; elemental analysis calcd. (%) for C50H29N3O·1/8CHCl3:
calcd. C 71.29, H 3.47, N 4.97; found C 71.19, H 3.44, N 4.98.
Oxidative Ring Contraction of 6b: A solution of KOH (800 mg)
in methanol (100 mL) was added to 6b (110 mg, 0.135 mmol) in
dichloromethane (110 mL), followed by the addition of 150 µL of
a solution of tert-butyl hydroperoxide in decane (5Ϫ6 ). The mix-
ture was stirred at room temperature in the dark under nitrogen
for 2 h. The mixture was diluted with chloroform, washed twice
with water, dried with sodium sulfate, filtered, and the solvents eva-
porated to dryness. The residue was loaded onto a silica flash chro-
matography column with CH2Cl2, and eluted with 30% hexanes/
dichloromethane. Three carbaporphyrin fractions corresponding to
20a (least polar), 20b, and 20c (most polar) were collected. Each
sample was recrystallized from chloroform/methanol to give pure
20a (28.7 mg, 26.5%, 0.0359 mmol), 20b (29.5 mg, 0.0351 mmol,
26.4%), and 20c (10.4 mg, 0.0126 mmol, 9.3%). Although the over-
all yields remained consistent, significant variations in the yield of
the minor product 20c was noted. However, the yield of 20c was
always Ͻ 10% and was commonly Ͻ 5%.
21-Formyl-5,10,15,20-tetrakis(4-chlorophenyl)benzo[b]carba-
porphyrin (20c): Blue-black solid, m.p. Ͼ 300 °C. UV/Vis (1% Et3N/
CHCl3): λmax (log10ε) ϭ 459 (5.22), 551 (4.15), 593 (3.97), 653
(3.56), 725 nm (3.80). UV/Vis (1% TFA/CHCl3): λmax (log10ε) ϭ
353 (4.47), 479 (5.01), 669 (4.02), 736 nm (4.025). UV/Vis (50%
TFA/CHCl3): λmax (log10ε) ϭ 368 (4.54), 478 (5.09), 559 (4.04), 662
(4.24), 742 nm (4.11). UV/Vis (TFA): λmax (log10ε) ϭ 347 (4.53),
463 (5.10), 598 (3.89), 648 (4.22), 732 nm (4.11). 1H NMR
(400 MHz, CDCl3): δ ϭ Ϫ4.96 (s, 1 H), Ϫ2.2 (v br, 2 H), 7.08 (d,
J ϭ 7.6 Hz, 1 H), 7.16 (t, J ϭ 7.6 Hz, 1 H), 7.49 (d, J ϭ 7.2 Hz, 1
H), 7.73Ϫ7.80 (m, 6 H), 7.88 (AAЈXXЈ system, 2 H), 8.02
(AAЈXXЈ system, 2 H), 8.10 (AAЈXXЈ system, 2 H), 8.26 (s, 2 H),
8.30 (AAЈXXЈ system, 2 H), 8.34 (d, J ϭ 5.2 Hz, 1 H), 8.38 (d, J ϭ
4.8 Hz, 1 H), 8.41 (AAЈXXЈ system, 2 H), 8.60 (d, J ϭ 4.8 Hz, 1
H), 8.70 (d, J ϭ 4.8 Hz, 1 H), 9.74 (s, 1 H) ppm. 13C NMR
(100 MHz, CDCl3): δ ϭ 105.4, 117.2, 118.0, 121.5, 123.6, 125.6,
126.2, 126.6, 126.7, 127.0, 127.1, 127.6, 127.7, 127.8, 128.8, 129.3,
129.4, 131.9, 132.6, 133.8, 134.1, 134.8, 134.9, 135.8, 135.9, 136.0,
136.1, 136.4, 136.6, 137.3, 137.8, 138.3, 138.8, 139.7, 139.9, 140.0,
140.1, 140.4, 155.7, 156.3, 189.9 ppm. HRMS (FAB): calculated
for C50H29N3Cl4O ϩ H: m/z ϭ 828.1143; found 828.1139.
5,10,15,20-Tetrakis(4-chlorophenyl)benzo[b]carbaporphyrin (20a):
Lustrous dark purple crystals, m.p. Ͼ 300 °C. UV/Vis (1% Et3N/
CHCl3): λmax (log10ε) ϭ 449 (5.28), 538 (4.21), 580 (3.93), 644
(3.58), 711 nm (3.69). UV/Vis (1% TFA/CHCl3): λmax (log10ε) ϭ
344 (4.50), 471 (5.11), 656 (4.18), 723 nm (4.01). UV/Vis (50% TFA/
CHCl3): λmax (log10ε) ϭ 464 (5.12), 675 nm (4.28). UV/Vis (TFA):
λmax (log10ε) ϭ 319 (4.47), 451 (5.33), 565 (3.89), 615 (4.07), 671 nm
1
(4.50). H NMR (400 MHz, CDCl3): δ ϭ Ϫ5.41 (s, 1 H), Ϫ2.7 (v
br, 2 H), 6.85Ϫ6.89 (m, 2 H), 7.03Ϫ7.06 (m, 2 H), 7.74 (AAЈBBЈ
system, 4 H), 7.82 (AAЈBBЈ system, 4 H), 8.07 (AAЈBBЈ system, 4
H), 8.26 (AAЈBBЈ system, 4 H), 8.45 (s, 2 H), 8.47 (d, J ϭ 4.8 Hz,
2 H), 8.63 (d, J ϭ 4.8 Hz, 2 H) ppm. 1H NMR (400 MHz, trace
TFA/CDCl3): δ ϭ Ϫ4.99 (s, 1 H), Ϫ3.82 (s, 1 H), Ϫ0.59 (s, 2 H),
6.86Ϫ6.90 (m, 2 H), 7.01Ϫ7.04 (m, 2 H), 7.86Ϫ7.89 (m, 8 H),
8.25Ϫ8.28 (m, 6 H), 8.37 (d, J ϭ 4 Hz, 2 H), 8.40 (d, J ϭ 8 Hz, 4
Oxidative Ring Contraction of 6a. Method A: Under the same con-
ditions reported above for the ring contraction of 6b, tetraphe-
nylazuliporphyrin 6a (105 mg, 0.156 mmol) and KOH (800 mg) in
CH2Cl2 (100 mL) and methanol (100 mL) was treated with 150 µL
of a 5 solution of tert-butyl hydroperoxide in decane. The crude
product was chromatographed on a silica flash column eluting with
20% hexanes/CH2Cl2, and then dichloromethane. Two carbapor-
phyrin fractions corresponding to 19a (least polar) and 19b were
collected. When the eluting solvent was changed to 50% CHCl3/
CH2Cl2, a third minor fraction 19c was obtained. Each sample was
recrystallized from chloroform/methanol to give pure 19a (29.8 mg,
29%), 19b (23.1 mg, 21.5%) and 19c (5.2 mg, 4.8%).
1
H), 8.66 (s, 2 H) ppm. H NMR (400 MHz, 50% TFA/CDCl3, up-
field region only): δ ϭ Ϫ2.12 (s, 2 H) ppm. 13C NMR (100 MHz,
CDCl3): δ ϭ 108.0, 117.4, 121.2, 123.8, 125.4, 126.7, 127.5, 128.6,
133.8, 134.6, 135.3, 135.9, 136.3, 138.2, 138.3, 138.5, 140.3, 140.5,
155.2 ppm. HRMS (EI): calculated for C49H29N3Cl4: m/z ϭ
799.1115; found 799.1112; elemental analysis calcd. (%) for
C49H29N3Cl4: calcd. C 73.42, H 3.65, N 5.24; found C 73.18, H
3.59, N 5.20.
Method B: Tetraphenylazuliporphyrin 6a (20.0 mg, 0.0296 mmol)
and KOH (230 mg) in CH2Cl2 (25 mL) and methanol (25 mL) was
treated with 150 µL of a 30% aqueous solution of hydrogen per-
oxide and stirred at room temperature for 2 hours. Following
workup and chromatography as described above, recrystallization
gave pure samples of 19a (3.5 mg, 18%) and 19b (6.0 mg, 29%).
A small amount of 19c was formed but this was not isolated in
pure form.
22-Formyl-5,10,15,20-tetrakis(4-chlorophenyl)benzo[b]carba-
porphyrin (20b): Brown-black solid, m.p. Ͼ 300 °C. UV/Vis (1%
Et3N/CHCl3): λmax (log10ε) ϭ 347 (4.52), 456 (5.34), 541 (4.31),
581 (3.86), 646 (3.59), 715 nm (3.85). UV/Vis (1% TFA/CHCl3):
λmax (log10ε) ϭ 347 (4.56), 472 (5.22), 653 (4.19), 729 nm (4.08).
UV/Vis (50% TFA/CHCl3): λmax (log10ε) ϭ 361 (4.56), 474 (5.17),
553 (4.20), 652 (4.225), 728 nm (4.12). UV/Vis (TFA): λmax
(log10ε) ϭ 348 (4.59), 462 (5.22), 593 (3.95), 642 (4.19), 722 nm 5,10,15,20-Tetraphenylbenzo[b]carbaporphyrin (19a): UV/Vis (1%
1
(4.11). H NMR (400 MHz, CDCl3): δ ϭ Ϫ5.20 (s, 1 H), Ϫ2.8 (v TFA/CHCl3): λmax (log10ε) ϭ 341 (4.49), 467 (5.115), 654 (4.16),
br, 2 H), 6.98 (d, J ϭ 8 Hz, 1 H), 7.24 (d, J ϭ 1 Hz, 1 H), 7.57
720 nm (4.015). UV/Vis (TFA): λmax (log10ε) ϭ 446 (5.26), 564
(dd, J ϭ 8, 1 Hz, 1 H), 7.75 (d, J ϭ 8.4 Hz, 4 H), 7.85 (d, J ϭ (3.71), 615 (3.935), 669 nm (4.22). 1H NMR (400 MHz, trace TFA/
8.4 Hz, 2 H), 7.87 (d, J ϭ 8.4 Hz, 2 H), 8.07Ϫ8.11 (2 overlapping CDCl3, monocation): δ ϭ Ϫ4.96 (s, 1 H), Ϫ3.83 (s, 1 H), Ϫ1.16 (s,
doublets, 4 H), 8.25Ϫ8.30 (2 overlapping doublets, 4 H), 8.50 (s, 2 2 H), 6.78Ϫ6.83 (m, 2 H), 6.94Ϫ6.98 (m, 2 H), 7.82Ϫ7.94 (m, 12
H), 8.50Ϫ8.53 (2 overlapping doublets, 2 H), 8.71 (d, J ϭ 4.8 Hz,
H), 8.30 (d, J ϭ 4 Hz, 2 H), 8.32Ϫ8.36 (m, 4 H), 8.42 (d, J ϭ
1 H), 8.73 (d, J ϭ 4.8 Hz, 1 H), 9.71 (s, 1 H) ppm. 1H NMR 4.8 Hz, 2 H), 8.44Ϫ8.49 (m, 4 H), 8.68 (s, 2 H) ppm. 13C NMR
(400 MHz, trace TFA/CDCl3): δ ϭ Ϫ4.66 (s, 1 H), Ϫ3.65 (s, 1 H), (100 MHz, trace TFA/CDCl3, monocation): δ ϭ 127.1, 127.2,
Ϫ0.52 (s, 2 H), 7.04 (d, J ϭ 8 Hz, 1 H), 7.33 (s, 1 H), 7.58 (d, J ϭ
8 Hz, 1 H), 7.88Ϫ7.94 (2 overlapping doublets, 8 H), 8.25Ϫ8.30
127.3, 127.9, 129.4, 130.0, 130.3, 130.7, 131.5, 132.0, 132.2, 133.2,
134.6, 137.4, 138.2, 138.7, 142.5, 145.5, 146.0, 146.5, 158.1 ppm.
(m, 6 H), 8.39Ϫ8.42 (m, 4 H), 8.45 (d, J ϭ 4.4 Hz, 2 H), 8.68 (s, 2 Elemental analysis calcd. (%) for C49H33N3·0.3CHCl3: calcd. C
H), 9.54 (s, 1 H) ppm. 13C NMR (100 MHz, CDCl3, 40 °C): δ ϭ
84.64, H 4.80, N 6.00; found C 84.78, H 4.74, N 6.00.[78]
Eur. J. Org. Chem. 2003, 4533Ϫ4548
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4545